2/11
07:26 pm
om
Outset Medical, Inc. (OM) Q4 2025 Earnings Call Transcript [Seeking Alpha]
Medium
Report
Outset Medical, Inc. (OM) Q4 2025 Earnings Call Transcript [Seeking Alpha]
2/11
07:22 pm
om
Outset Medical outlines 5%–9% revenue growth for 2026 with next-gen Tablo launch and gross margin expansion [Seeking Alpha]
Medium
Report
Outset Medical outlines 5%–9% revenue growth for 2026 with next-gen Tablo launch and gross margin expansion [Seeking Alpha]
2/11
06:28 pm
om
Outset Medical Q4 Earnings Call Highlights [Yahoo! Finance]
Medium
Report
Outset Medical Q4 Earnings Call Highlights [Yahoo! Finance]
2/11
04:02 pm
om
Outset Medical Reports Fourth Quarter and Full Year 2025 Financial Results
Neutral
Report
Outset Medical Reports Fourth Quarter and Full Year 2025 Financial Results
2/9
02:43 pm
om
Stifel Lowers Price Target on Outset Medical, Inc. (OM) to $8, Maintains Buy Rating [Yahoo! Finance]
Low
Report
Stifel Lowers Price Target on Outset Medical, Inc. (OM) to $8, Maintains Buy Rating [Yahoo! Finance]
2/8
02:04 am
om
1/31
01:33 am
om
Low
Report
1/28
07:13 am
om
Outset Medical secures FDA clearance for Tablo haemodialysis system [Yahoo! Finance]
High
Report
Outset Medical secures FDA clearance for Tablo haemodialysis system [Yahoo! Finance]
1/27
09:00 am
om
Next-Generation Tablo Hemodialysis System Receives FDA Clearance, Second Quarter Launch Planned
Medium
Report
Next-Generation Tablo Hemodialysis System Receives FDA Clearance, Second Quarter Launch Planned
1/26
04:05 pm
om
Outset Medical to Report Fourth Quarter 2025 Financial Results on Wednesday, February 11, 2026
Medium
Report
Outset Medical to Report Fourth Quarter 2025 Financial Results on Wednesday, February 11, 2026
1/13
07:07 pm
om
Outset Medical (OM) Soars 22.2%: Is Further Upside Left in the Stock? [Yahoo! Finance]
Medium
Report
Outset Medical (OM) Soars 22.2%: Is Further Upside Left in the Stock? [Yahoo! Finance]
1/12
10:07 am
om
Download the CNN app [CNN]
Medium
Report
Download the CNN app [CNN]
1/12
08:30 am
om
Outset Medical Reports Unaudited Fourth Quarter and 2025 Results
High
Report
Outset Medical Reports Unaudited Fourth Quarter and 2025 Results
1/10
01:07 am
om
1/8
10:00 am
om
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Outset Medical, Inc. - OM
Medium
Report
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Outset Medical, Inc. - OM
1/7
09:24 am
om
Outset Medical (NASDAQ:OM) had its price target lowered by analysts at Stifel Nicolaus from $14.00 to $8.00. They now have a "buy" rating on the stock.
Low
Report
Outset Medical (NASDAQ:OM) had its price target lowered by analysts at Stifel Nicolaus from $14.00 to $8.00. They now have a "buy" rating on the stock.
1/6
12:31 pm
om
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Outset Medical, Inc. - OM
Medium
Report
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Outset Medical, Inc. - OM
1/5
04:05 pm
om
Outset Medical to Present at the 44th Annual J.P. Morgan Healthcare Conference
High
Report
Outset Medical to Present at the 44th Annual J.P. Morgan Healthcare Conference
1/1
10:00 am
om
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Outset Medical, Inc. - OM
Low
Report
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Outset Medical, Inc. - OM
12/30
04:21 pm
om
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Outset Medical, Inc. - OM
Low
Report
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Outset Medical, Inc. - OM
12/17
10:10 am
om
Outset Medical (NASDAQ:OM) had its "sector perform" rating reaffirmed by analysts at Royal Bank Of Canada.
Medium
Report
Outset Medical (NASDAQ:OM) had its "sector perform" rating reaffirmed by analysts at Royal Bank Of Canada.
12/16
08:05 am
om
Outset Medical (NASDAQ:OM) had its "buy" rating reaffirmed by analysts at BTIG Research. They now have a $17.00 price target on the stock.
Medium
Report
Outset Medical (NASDAQ:OM) had its "buy" rating reaffirmed by analysts at BTIG Research. They now have a $17.00 price target on the stock.
12/13
01:10 am
om
Medium
Report
12/11
10:00 am
om
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Outset Medical, Inc. - OM
Low
Report
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Outset Medical, Inc. - OM
12/10
04:10 am
om
Outset Medical (NASDAQ:OM) had its "sell (e+)" rating reaffirmed by analysts at
Weiss Ratings.
Low
Report
Outset Medical (NASDAQ:OM) had its "sell (e+)" rating reaffirmed by analysts at
Weiss Ratings.